| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/03/1997 | WO1997012246A1 Tumour-specific p450 protein |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
| 04/03/1997 | WO1997011707A1 Modified ether glyceroglycolipids |
| 04/03/1997 | WO1997011699A1 1,2,4-benzotriazine oxides formulations |
| 04/03/1997 | WO1997011667A2 Therapeutic applications using horse serum |
| 04/03/1997 | WO1997011666A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | CA2233445A1 2-mercaptoethanolamine, copper di-isopropyl salicylate, and related compounds |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233168A1 Modified ether glyceroglycolipids |
| 04/03/1997 | CA2233015A1 Therapeutic applications using horse serum |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765866A2 Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof |
| 04/02/1997 | EP0765386A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765329A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765321A1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0765167A1 Suppression of tumor cell growth by syndecan-1 ectodomain |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
| 04/02/1997 | CN1146769A Method for stabilizing compound DX-52-1 and lyophilized composition thereof |
| 04/02/1997 | CN1146722A Taxane class derivative based pharmaceutical compositions |
| 04/02/1997 | CN1146361A Aitongning oral liquid (for relieving cancer pain) |
| 04/02/1997 | CN1146351A Pellet with immunity detoxication function and preparation method |
| 04/01/1997 | US5616759 Cyclohexylidene compounds |
| 04/01/1997 | US5616740 Process for making 9-deoxotaxane compounds |
| 04/01/1997 | US5616739 Method of preparing taxane derivatives |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616709 Method of synthesis for 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616589 Bis-naphthalimides for the treatment of cancer |
| 04/01/1997 | US5616582 Use as anticancer agents; e.g. gefitinib |
| 04/01/1997 | US5616574 Steroid sulphatase inhibitors |
| 04/01/1997 | US5616567 2'-Cyano pyrimidine nucleoside compounds |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
| 04/01/1997 | US5616330 Taxine, a triglyceride, water and a surfactant; anticarcinogenic agent |
| 04/01/1997 | US5616323 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic or pharmaceutical composition or food composition containing such an extract |
| 04/01/1997 | CA2042426C Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011174A1 Cyclin depenpent kinase binding compounds |
| 03/27/1997 | WO1997011171A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | WO1997011091A1 Novel peptide compounds and medicinal compositions thereof |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997011087A1 L-nucleoside dimer compounds and therapeutic uses |
| 03/27/1997 | WO1997010854A1 (radio) labelled biotin derivatives |
| 03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/27/1997 | WO1997010809A1 Lyophilized thioxanthenone antimumor agents |
| 03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 03/27/1997 | WO1997005873A3 Use of fluconazole for inhibiting the growth of cancers |
| 03/27/1997 | WO1997005872A3 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers |
| 03/27/1997 | WO1997005859A3 Use of alicyclic diamines as immunomodulators |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997001344A3 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 03/27/1997 | WO1996040728A3 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232724A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | CA2232444A1 Lyophilized thioxanthenone antitumor agents |
| 03/27/1997 | CA2232411A1 (radio) labelled biotin derivatives |
| 03/27/1997 | CA2206878A1 L-nucleoside dimer compounds and therapeutic uses |
| 03/27/1997 | CA2183917A1 Preparation of optically active (s)-(-) and (r)-(+)- deoxyspergualin and novel intermediates thereof |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764156A1 New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764155A1 Taxoids, preparation and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764154A1 New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764149A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 03/26/1997 | EP0764027A1 Method for protection against genotoxic mutagenesis |
| 03/26/1997 | EP0764021A1 Uterine fibroid treatment |
| 03/26/1997 | EP0696279B1 Oxidation products of cephalomannine |
| 03/26/1997 | EP0680470B1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | EP0546087B1 Protein structure of the plant toxin gelonin |
| 03/26/1997 | EP0500739B1 Herbal treatment of malignancy |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1145908A New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them |
| 03/26/1997 | CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/26/1997 | CN1145804A Medicine for gastropathy "kuleweikang" |